Home
Conditions
Esophageal Cancer

Clinical trial condition

Esophageal Cancer

Explore clinical trials studying Esophageal Cancer. Study availability and eligibility vary by location and protocol.

720 public trials 179 recruiting studies

Refine in advanced search Browse all conditions

Esophageal Cancer trial results

Completed

Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers

NCT02349412

Conditions: Adenoma, Anxiety Disorder, Anxiety Disorders, +48 more
Locations: UC San Diego Moores Cancer Center La Jolla, California, United States

Queen's Medical Center Honolulu, Hawaii, United States

University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States

NorthShore University HealthSystem-Evanston Hospital Evanston, Illinois, United States

View all 23 locations

View Trial Details

Completed

Establishment of Molecular Classification Models for Early Diagnosis of Digestive System Cancers

NCT05431621

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +24 more
Locations: Xuhui Central Hospital, Shanghai Shanghai, Shanghai Municipality, China

Zhongshan Hospital of Fudan University Shanghai, Shanghai Municipality, China

Shanghai Public Health Clinical Center Shanghai, Shanghai Municipality, China

Qingpu Branch of Zhongshan Hospital Affiliated to Fudan University Shanghai, Shanghai Municipality, China

View Trial Details

Completed

Intestinal Microbiome, Oral Microbiome, and Whole Blood Transcriptome Analyses in Gastrointestinal Malignancies

NCT05462314

Conditions: Biliary Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +32 more
Locations: Icahn School of Medicine at Mount Sinai New York, United States

View Trial Details

Completed

The Effect of Prophylactic TPO Combined with BMS-IMRT to Esophageal Cancer Patients

NCT05944809

Conditions: Blood Platelet Disorders, Concurrent Chemoradiotherapy, Cytopenia, +14 more
Locations: Department of Radiation Oncology, Cancer Institute and Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College Beijing, Beijing Municipality, China

View Trial Details

Completed

Second-line Cabozantinib and Atezolizumab in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma

NCT05007613

Conditions: Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +18 more
Locations: National Taiwan University Hospital Taipei, Taiwan

View Trial Details

Completed

Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumab

NCT04164069

Conditions: Advanced Colorectal Carcinoma, Bile Duct Cancer, Bile Duct Diseases, +41 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Completed

The Registry of Oncology Outcomes Associated With Testing and Treatment

NCT04028479

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Adenocarcinoma, +249 more
Locations: Teton Cancer Institute Idaho Falls, Idaho, United States

Oncology and Hematology of South Texas Laredo, Texas, United States

View Trial Details

Completed

A First in Human, Dose Escalation Study of JAB-3068 （SHP2 Inhibitor） in Adult Patients With Advanced Solid Tumors

NCT03518554

Conditions: Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +40 more
Locations: HealthONE Clinic Services Oncology-Hematology Denver, Colorado, United States

Florida Cancer Specialists Sarasota, Florida, United States

Sarah Cannon Research Institute Nashville, Tennessee, United States

The University of Texas M. D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

A Prospective Study Frailty for Esophagectomy and Lung Resection in Thoracic Surgery

NCT03413449

Conditions: Atrophy, Digestive System Diseases, Digestive System Neoplasms, +30 more
Locations: Cleveland Clinic Foundation Cleveland, Ohio, United States

View Trial Details

Completed

Octreotide Treatment to Improve Nutritional Recovery After Surgery for Patients with Esophageal or Gastric Cancer

NCT04871204

Conditions: Body Weight, Body Weight Changes, Digestive System Diseases, +15 more
Locations: Karolinska University Hospital, Huddinge Stockholm, Sweden

View Trial Details

Esophageal Cancer

Esophageal Cancer trial results

Related conditions